Cargando…

Characterization of FcγRIa (CD64) as a Ligand Molecule for Site-Specific IgG1 Capture: A Side-By-Side Comparison with Protein A

[Image: see text] Fc γ receptors (FcγRs) are one of the structures that can initiate effector function for monoclonal antibodies. FcγRIa has the highest affinity toward IgG1-type monoclonal antibodies among all FcγRs. In this study, a comprehensive characterization was performed for FcγRIa as a pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Capkin, Eda, Kurt, Hasan, Gurel, Busra, Bicak, Dilan, Akgun Bas, Sibel, Daglikoca, Duygu Emine, Yuce, Meral
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730901/
https://www.ncbi.nlm.nih.gov/pubmed/36416530
http://dx.doi.org/10.1021/acs.langmuir.2c02022
_version_ 1784845785523814400
author Capkin, Eda
Kurt, Hasan
Gurel, Busra
Bicak, Dilan
Akgun Bas, Sibel
Daglikoca, Duygu Emine
Yuce, Meral
author_facet Capkin, Eda
Kurt, Hasan
Gurel, Busra
Bicak, Dilan
Akgun Bas, Sibel
Daglikoca, Duygu Emine
Yuce, Meral
author_sort Capkin, Eda
collection PubMed
description [Image: see text] Fc γ receptors (FcγRs) are one of the structures that can initiate effector function for monoclonal antibodies. FcγRIa has the highest affinity toward IgG1-type monoclonal antibodies among all FcγRs. In this study, a comprehensive characterization was performed for FcγRIa as a potential affinity ligand for IgG1-type monoclonal antibody binding. The binding interactions were assessed with the SPR technique using different immobilization techniques such as EDC-NHS coupling, streptavidin–biotin interaction, and His-tagged FcγRIa capture. The His-tagged FcγRIa capture was the most convenient method based on assay repeatability. Next, a crude IgG1 sample and its fractions with different monomer contents obtained from protein A affinity chromatography were used to evaluate FcγRIa protein in terms of monoclonal antibody binding capacity. The samples were also compared with a protein A-immobilized chip (a frequently used affinity ligand) for IgG1 binding responses. The antibody binding capacity of the protein A-immobilized chip surface was significantly better than that of the FcγRIa-immobilized chip surface due to its 5 Ig binding domains. The antibody binding responses changed similarly with protein A depending on the monomer content of the sample. Finally, a different configuration was used to assess the binding affinity of free FcγRs (FcγRIa, FcγRIIa, and FcγRIIIa) to three different immobilized IgGs by immobilizing protein L to the chip surface. Unlike previous immobilization techniques tested where the FcγRIa was utilized as a ligand, nonimmobilized or free FcγRIa resulted in a significantly higher antibody binding response than free protein A. In this configuration, kinetics data of FcγRI revealed that the association rate (k(a) 50–80 × 10(5) M(–1) s(–1)) increased in comparison to His capture method (1.9–2.4 × 10(5) M(–1) s(–1)). In addition, the dissociation rate (k(d) 10(–5) s(–1)) seemed slower over the His capture method (10(–4) s(–1)) and provided stability on the chip surface during the dissociation phase. The K(D) values for FcγRIa were found in the picomolar range (2.1–10.33 pM from steady-state affinity analysis and 37.5–46.2 pM from kinetic analysis) for IgG1-type antibodies. FcγRIa possesses comparable ligand potential as well as protein A. Even though the protein A-immobilized surface bound more antibodies than the FcγRIa-captured surface, FcγRIa presented a significant antibody binding capacity in protein L configuration. The results suggest FcγRIa protein as a potential ligand for site-oriented immobilization of IgG1-type monoclonal antibodies, and it needs further performance investigation on different surfaces and interfaces for applications such as sensing and antibody purification.
format Online
Article
Text
id pubmed-9730901
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-97309012022-12-09 Characterization of FcγRIa (CD64) as a Ligand Molecule for Site-Specific IgG1 Capture: A Side-By-Side Comparison with Protein A Capkin, Eda Kurt, Hasan Gurel, Busra Bicak, Dilan Akgun Bas, Sibel Daglikoca, Duygu Emine Yuce, Meral Langmuir [Image: see text] Fc γ receptors (FcγRs) are one of the structures that can initiate effector function for monoclonal antibodies. FcγRIa has the highest affinity toward IgG1-type monoclonal antibodies among all FcγRs. In this study, a comprehensive characterization was performed for FcγRIa as a potential affinity ligand for IgG1-type monoclonal antibody binding. The binding interactions were assessed with the SPR technique using different immobilization techniques such as EDC-NHS coupling, streptavidin–biotin interaction, and His-tagged FcγRIa capture. The His-tagged FcγRIa capture was the most convenient method based on assay repeatability. Next, a crude IgG1 sample and its fractions with different monomer contents obtained from protein A affinity chromatography were used to evaluate FcγRIa protein in terms of monoclonal antibody binding capacity. The samples were also compared with a protein A-immobilized chip (a frequently used affinity ligand) for IgG1 binding responses. The antibody binding capacity of the protein A-immobilized chip surface was significantly better than that of the FcγRIa-immobilized chip surface due to its 5 Ig binding domains. The antibody binding responses changed similarly with protein A depending on the monomer content of the sample. Finally, a different configuration was used to assess the binding affinity of free FcγRs (FcγRIa, FcγRIIa, and FcγRIIIa) to three different immobilized IgGs by immobilizing protein L to the chip surface. Unlike previous immobilization techniques tested where the FcγRIa was utilized as a ligand, nonimmobilized or free FcγRIa resulted in a significantly higher antibody binding response than free protein A. In this configuration, kinetics data of FcγRI revealed that the association rate (k(a) 50–80 × 10(5) M(–1) s(–1)) increased in comparison to His capture method (1.9–2.4 × 10(5) M(–1) s(–1)). In addition, the dissociation rate (k(d) 10(–5) s(–1)) seemed slower over the His capture method (10(–4) s(–1)) and provided stability on the chip surface during the dissociation phase. The K(D) values for FcγRIa were found in the picomolar range (2.1–10.33 pM from steady-state affinity analysis and 37.5–46.2 pM from kinetic analysis) for IgG1-type antibodies. FcγRIa possesses comparable ligand potential as well as protein A. Even though the protein A-immobilized surface bound more antibodies than the FcγRIa-captured surface, FcγRIa presented a significant antibody binding capacity in protein L configuration. The results suggest FcγRIa protein as a potential ligand for site-oriented immobilization of IgG1-type monoclonal antibodies, and it needs further performance investigation on different surfaces and interfaces for applications such as sensing and antibody purification. American Chemical Society 2022-11-23 2022-12-06 /pmc/articles/PMC9730901/ /pubmed/36416530 http://dx.doi.org/10.1021/acs.langmuir.2c02022 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Capkin, Eda
Kurt, Hasan
Gurel, Busra
Bicak, Dilan
Akgun Bas, Sibel
Daglikoca, Duygu Emine
Yuce, Meral
Characterization of FcγRIa (CD64) as a Ligand Molecule for Site-Specific IgG1 Capture: A Side-By-Side Comparison with Protein A
title Characterization of FcγRIa (CD64) as a Ligand Molecule for Site-Specific IgG1 Capture: A Side-By-Side Comparison with Protein A
title_full Characterization of FcγRIa (CD64) as a Ligand Molecule for Site-Specific IgG1 Capture: A Side-By-Side Comparison with Protein A
title_fullStr Characterization of FcγRIa (CD64) as a Ligand Molecule for Site-Specific IgG1 Capture: A Side-By-Side Comparison with Protein A
title_full_unstemmed Characterization of FcγRIa (CD64) as a Ligand Molecule for Site-Specific IgG1 Capture: A Side-By-Side Comparison with Protein A
title_short Characterization of FcγRIa (CD64) as a Ligand Molecule for Site-Specific IgG1 Capture: A Side-By-Side Comparison with Protein A
title_sort characterization of fcγria (cd64) as a ligand molecule for site-specific igg1 capture: a side-by-side comparison with protein a
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730901/
https://www.ncbi.nlm.nih.gov/pubmed/36416530
http://dx.doi.org/10.1021/acs.langmuir.2c02022
work_keys_str_mv AT capkineda characterizationoffcgriacd64asaligandmoleculeforsitespecificigg1captureasidebysidecomparisonwithproteina
AT kurthasan characterizationoffcgriacd64asaligandmoleculeforsitespecificigg1captureasidebysidecomparisonwithproteina
AT gurelbusra characterizationoffcgriacd64asaligandmoleculeforsitespecificigg1captureasidebysidecomparisonwithproteina
AT bicakdilan characterizationoffcgriacd64asaligandmoleculeforsitespecificigg1captureasidebysidecomparisonwithproteina
AT akgunbassibel characterizationoffcgriacd64asaligandmoleculeforsitespecificigg1captureasidebysidecomparisonwithproteina
AT daglikocaduyguemine characterizationoffcgriacd64asaligandmoleculeforsitespecificigg1captureasidebysidecomparisonwithproteina
AT yucemeral characterizationoffcgriacd64asaligandmoleculeforsitespecificigg1captureasidebysidecomparisonwithproteina